Search Results

Showing results 31 - 40 of 1502.
Sort By: Date ▼

Jury orders J&J to pay patient $8B over antipsychotic Risperdal

October 10, 2019


A Philadelphia jury on Tuesday ordered New Jersey-based Johnson & Johnson (J&J) to pay $8 billion in punitive damages to a Maryland man who claimed J&J failed to properly warn patients and providers that its antipsychotic drug Risperdal could spur breast growth in boys.

SCOTUS declines to hear MS drug patent case

October 9, 2019


The Supreme Court on Monday denied drugmaker Acorda Therapeutics' request to hear a case regarding patents for the company's multiple sclerosis treatment Ampyra, meaning generic versions of the drug can remain on the market.

SCOTUS to hear case challenging Louisiana abortion requirements

October 8, 2019


The Supreme Court on Friday announced that it will hear a case challenging a Louisiana law that would impose new requirements on abortion providers, marking the first major abortion-related case the high court will hear since President Trump's conservative-leaning justice nominees were confirmed.

Personal injury lawsuit ads targeting drugmakers might be 'deceptive,' FTC warns

October 7, 2019


The Federal Trade Commission last month sent warning letters to seven law firms and marketing companies, warning that their ads seeking patients for personal injury lawsuits against drugmakers could violate federal law and cause patients to avoid taking their medications.

Federal judge OKs nation's first 'safe injection' site

October 4, 2019


A federal judge this week ruled that a Philadelphia nonprofit can open a medically supervised injection site under U.S. law, an unprecedented ruling that could open the door for other cities to pursue so-called "safe-injection" sites to combat the opioid epidemic.

J&J reaches $20.4M settlement in 'bellwether' opioid lawsuit

October 2, 2019


Johnson & Johnson on Tuesday announced that it has reached an agreement with two Ohio counties to settle claims, with no admission of liability, that the drugmaker contributed to the U.S. opioid epidemic.

HHS reallocates Planned Parenthood funding to other Title X participants

October 2, 2019


The Trump administration has reallocated federal funding totaling $34 million that became available when Planned Parenthood and other providers exited the Title X program because of new restrictions regarding abortion.

Hospitals question legality of CMS' price transparency proposal

October 1, 2019


CMS' public comment period for the 2020 Hospital Outpatient Perspective Payment System proposed rule ended last week, and the rule's more controversial proposals garnered hundreds of comments from hospital groups, insurers, and other industry stakeholders.

DOJ charges 35 individuals in $2B Medicare scam

October 1, 2019


The Department of Justice last week announced that it has brought charges against 35 individuals, including 10 medical professionals, for their alleged role in a Medicare scam involving dozens of telemedicine companies and genetic testing laboratories.

Results Page: [Previous] 1 2 3 4 5  ... [Next]